Overweight or Obesity Clinical Trial
Official title:
Randomized, Double-blinded, Placebo-controlled, Multicenter Trial Investigating Performance and Safety of the Medical Device SiPore21® in Obese or Overweight Subjects With Elevated Blood Glucose Levels
The present clinical investigation is a randomized, double-blinded, placebo-controlled, multicenter international trial, planned to be conducted in Poland, Romania and Slovakia. The investigation will be performed to establish clinical evidence regarding the performance and safety of the IMD and is aiming at evaluating the suitability of the IMD for the intended purpose and population.
The proposed investigation is set out to be a randomized, double blind, placebo-controlled, multicenter study according to MDR Article 62 to investigate performance and safety of the medical device SiPore21® in subjects with obesity or overweight and elevated blood glucose levels. The aim of this clinical investigation is to evaluate the clinical performance of the IMD for blood glucose control and its clinical safety. The endpoints selected to evaluate the effects of the IMD are based on the state-of-the-art assessments of blood glucose control (ADA, 2022). The main hypothesis is that treatment with SiPore21® for 12 weeks will reduce the HbA1c in obese or overweight subjects with elevated blood glucose levels. It is further hypothesized that treatment with SiPore21® for 12 weeks will result in a reduction in body weight and influence metabolic control parameters and lipid levels. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT06013163 -
A Phase 1 Study to Evaluate EMP22 PD and EMP16 PK Versus Xenical® in Healthy Volunteers
|
Phase 1 | |
| Active, not recruiting |
NCT03843424 -
Treatment Efforts Addressing Child Weight Management by Unifying Patients, Parents & Providers
|
N/A | |
| Not yet recruiting |
NCT06360536 -
Remotely Delivered Resistance Training for Cardiometabolic Health Among Black Women
|
N/A | |
| Not yet recruiting |
NCT05997576 -
A Study of TG103 Injection in Non-diabetic Overweight or Obesity
|
Phase 3 | |
| Recruiting |
NCT04763291 -
Cardiovascular and InflammAging Study
|
N/A | |
| Active, not recruiting |
NCT04399460 -
The Effects of Long-term Consumption of Full-fat Dairy Products on Satiety, Body Weight and Glycemic Control
|
N/A | |
| Completed |
NCT04451824 -
Examination of Circumferential Reduction
|
N/A | |
| Completed |
NCT04110717 -
Electrical Vestibular Nerve Stimulation (VeNS) Compared to Sham Control as a Means of Reducing Excess Body Weight
|
N/A | |
| Completed |
NCT05561855 -
T2DM Intensity Lifestyle Intervention
|
N/A | |
| Active, not recruiting |
NCT04100200 -
Berries, Inflammation, and Gut Microbiome
|
N/A | |
| Recruiting |
NCT06125964 -
eMOTION Formative Study
|
N/A | |
| Active, not recruiting |
NCT04328233 -
Impact of Time-Restricted Eating on Metabolic Homeostasis, Inflammation and Oxidative Stress in Metabolic Syndrome
|
N/A | |
| Completed |
NCT06091761 -
Thread Embedding Acupuncture Combined With Auricular Acupuncture for Overweight and Obesity
|
N/A | |
| Completed |
NCT04894344 -
Education to Decrease in Sodium Intake Evaluated With 24 Hour Urinary Sodium Excretion (RCT)
|
N/A | |
| Completed |
NCT05713461 -
Physical Exercise in Obesity for Health and Quality of Life.
|
N/A | |
| Not yet recruiting |
NCT06054698 -
Efficacy and Safety of HRS9531 Injections in Overweight or Obese Subjects
|
Phase 2 | |
| Not yet recruiting |
NCT02823912 -
Capsaicin Effect on Cytokines Profile in Dyslipidemia
|
Phase 2/Phase 3 | |
| Completed |
NCT05104151 -
Efficacy of a Nutritive Bar, in Reduction of Weight, Body Fat and Control of Appetite
|
N/A | |
| Completed |
NCT04786925 -
Precision Nutrition Strategies for Improving the Quality of Life of Pre-senior and Senior Populations
|
N/A | |
| Enrolling by invitation |
NCT06092632 -
Efficacy of Pigmented Rice on Reducing Cardiometabolic Risk Factors Among Filipino Adults
|
N/A |